Tech Blog: New Drug Treatment For Ewing’s Sarcoma

Tech Launch AZ

Funded by the American Cancer Society and the National Cancer Institute at the National Institute of Health, Dr. Jacob Schwartz, an Assistant Professor in the UA Department of Chemistry and Biochemistry and BIO5 faculty, has created a new drug treatment for a class of cancers. Dr. Schwartz’s primary focus is Ewing’s sarcoma, a childhood cancer that is driven by proteins he and his students are investigating.